Johnson & Johnson to spin out orthopedics businessnews2025-10-14T11:01:12+00:00October 14th, 2025|Endpoints News|
Novavax’s second-largest shareholder calls for sale of vaccine makernews2025-10-14T10:49:36+00:00October 14th, 2025|Endpoints News|
Three big questions ahead of third-quarter pharma earningsnews2025-10-13T20:09:50+00:00October 13th, 2025|Endpoints News|
California enacts state law building on PBM reformsnews2025-10-13T19:24:46+00:00October 13th, 2025|Endpoints News|
FDA hands OAI classification to Novo Nordisk’s troubled Indiana sitenews2025-10-13T15:38:49+00:00October 13th, 2025|Endpoints News|
AstraZeneca strikes pricing deal with Trumpnews2025-10-10T22:21:21+00:00October 10th, 2025|Endpoints News|
WuXi companies left out of latest version of Biosecure Actnews2025-10-10T19:20:46+00:00October 10th, 2025|Endpoints News|
J&J is in discussions to buy out Protagonist Therapeutics — reportnews2025-10-10T17:04:46+00:00October 10th, 2025|Endpoints News|
White House, AstraZeneca expected to announce drug price dealnews2025-10-10T16:51:36+00:00October 10th, 2025|Endpoints News|
Bristol Myers joins in vivo CAR-T race with $1.5B Orbital acquisitionnews2025-10-10T11:28:23+00:00October 10th, 2025|Endpoints News|
